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Although DNAmodifications play an important role in
gene regulation, the underlying mechanisms remain
elusive. We developed EpiSELEX-seq to probe the
sensitivityof transcription factorbinding toDNAmodi-
fication in vitro using massively parallel sequencing.
Feature-based modeling quantifies the effect of cyto-
sinemethylation (5mC) on binding free energy in a po-
sition-specificmanner. Application to the humanbZIP
proteins ATF4 and C/EBPb and three different Pbx-
Hox complexes shows that 5mCpG can both increase
anddecrease affinity, depending onwhere themodifi-
cationoccurswithin theprotein-DNA interface. TheTF
paralogs tested vary in their methylation sensitivity,
for which we provide a structural rationale. We show
that 5mCpG can also enhance in vitro p53 binding
and provide evidence for increased in vivo p53 occu-
pancy at methylated binding sites, correlating with
primed enhancer histonemarks. Our results establish
a powerful strategy for dissecting the epigenomic
modulation of protein-DNA interactions and their
role in gene regulation.
INTRODUCTION
High-throughput profiling of in vitro transcription factor (TF) bind-
ing specificities is a powerful approach for obtaining sequence
motifs for a variety of TF families and in several different organ-
isms (Badis et al., 2009; Jolma et al., 2013; Weirauch et al.,
2014). However, despite the growing number of known TF mo-
tifs, accurate prediction of in vivo TF binding and its effect on
target gene expression has remained surprisingly difficult. One
of the complications is that protein-protein interactions can
modify the DNA binding specificities of transcription factors
(Jolma et al., 2015;Miller, 2009; Slattery et al., 2011). Another po-
tential complication is the existence of covalent modifications of
DNA, particularly cytosine methylation (5mCpG), which is wide-
spread in vertebrates. Because of their potential to alter the chro-
matin state (Hashimshony et al., 2003) or DNA shape (LazaroviciCell
This is an open access article under the CC BY-Net al., 2013), an important and hotly debated question is to
what extent DNA modifications can influence TF binding and,
thereby, contribute to changes in the epigenetic landscape
and gene regulation. Such a regulatory mechanism is conceptu-
ally compelling because DNA modifications could provide an
additional layer of temporal and spatial control to fine-tune
gene expression.
5mCpG has been shown to be important in gene silencing
in normal and cancer cells (Jones and Baylin, 2007; Stein
et al., 1982), gene imprinting (Razin and Cedar, 1994), and
X chromosome inactivation (Hellman and Chess, 2007; Tribioli
et al., 1992). In spite of this progress, there is no general
mechanism explaining the effect of DNA methylation on gene
expression (Dantas Machado et al., 2015). Several studies
have found that, despite the overall association between pro-
moter methylation and transcriptional silencing, some pro-
moters can simultaneously be methylated and transcriptionally
active (Gutierrez-Arcelus et al., 2013). In addition, systematic
studies with cancer cell lines have found that aberrant methyl-
ation, such as hypermethylation of specific CpG islands, is
a hallmark of cancer progression (Baylin and Jones, 2011;
Paz et al., 2003). Recent studies have identified additional
modifications, such as 5-hydroxy-methylcytosine (5hmC) and
N6-methyladenine (6mA), in mammalian genomes, raising the
possibility that these also influence gene regulation (Fu et al.,
2015; Greer et al., 2015; Zhang et al., 2015). To identify the
causal determinants of in vivo TF binding among all of these
correlated variables, detailed quantitative characterization of
the effect of DNA modification on in vitro transcription factor
binding is a prerequisite.
On a limited scale, the in vitro platform of protein binding mi-
croarrays (PBMs) has been used to probe TF binding to methyl-
ated DNA probes (Hu et al., 2013; Mann et al., 2013). These
studies demonstrated that 5mCpGs can have both positive and
negative effects on affinity. However, they were limited by the
fact that the DNA arrays contained either fully methylated or fully
un-methylated sequences (Mann et al., 2013), but not both in
competition, or they only considered a select subset of se-
quences (Hu et al., 2013). In addition, the data analysis in these
studieswas restricted to oligomer-basedmethods, whichmakes
it difficult to identify position-specific effects, especially for
lower-affinity binding sites that deviate from the consensusReports 19, 2383–2395, June 13, 2017 ª 2017 The Author(s). 2383
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motif. To study the effect of cytosine methylation on TF binding
at high resolution, a quantitative assay is required that allows
simultaneous probing of methylated and unmethylated DNA
probes across all possible sequence contexts.
To address these issues, we developed EpiSELEX-seq, a
method that uses a single round of gel electrophoresis to simul-
taneously assess binding to methylated and unmethylated DNA
fragments, thus allowing methylation sensitivity to be analyzed
for any TF or TF complex. We apply EpiSELEX-seq to human
basic leucine zipper (bZIP) and Hox complexes as well as tetra-
mers of the tumor suppressor protein p53. Using a feature-
based Poisson regression model, we quantify position-specific
methylation effects on in vitro binding in the low-affinity range.
For p53, by jointly analyzing whole-genome bisulfite sequencing
and in vivo binding (chromatin immunoprecipitation sequencing
[ChIP-seq]) data, we provide evidence that the increased in vitro
affinity for specific DNA sequences because ofmethylation leads
to enhanced occupancy in vivo. These sites of increased binding
have a histone modification pattern associated with primed en-
hancers, supporting a role for p53 as a pioneer factor that can
access methylated DNA sites.
RESULTS
Affinity-Based Selection from Mixed Pools of
Methylated and Unmethylated DNA Ligands
To quantitatively assess the effects of DNA methylation on TF
binding, we developed a method in which a methylated library
(Lib-M) and an unmethylated library (Lib-U) containing a random-
ized region of a desired length (16 bp or 26 bp) were first sepa-
rately synthesized, each distinguished by a unique 4-bp bar
code located near the variable region (Figure 1A). After treatment
of Lib-M with a DNA methyltransferase, both libraries were
mixed in equal proportions, incubated with a TF of interest,
and subjected to a single round of electrophoretic mobility shift
assay (EMSA) selection. Sequencing libraries were prepared
from the library mix both before (R0) and after (R1) affinity-based
selection (Figure 1B; Figures S1A and S1B). For each sequenced
DNA ligand, the bar code allows us to reconstruct the methyl-
ation status at the time of TF binding.
For accurate affinity estimation, it is important that the two cy-
tosines in each CpG base-pair step in Lib-M be fully methylated
because incomplete methylation would lead to underestimation
of the effect of 5mCpG on TF binding. We employed two sepa-
rate tests to confirm full methylation: methylation, bisulfite treat-
ment, and sub-cloning of a test sequence containing four CpGs
and high-throughput sequencing followed by dinucleotide anal-
ysis of a Lib-M that was either treated or not treatedwith bisulfite.
In the first test, we determined that optimal methylation effi-
ciency is achieved after two successive rounds of methylation
with% 250 ng of input DNA per reaction (Table S1). Using larger
amounts of DNA (e.g., the recommended 1 mg) resulted in incom-
plete methylation of the test probes. The short size of our probes
(50 bp) comparedwith typical genomic fragments (>1 kb)might
be the source of this discrepancy because suboptimal condi-
tions typically resulted in the methylation of either all four CpGs
or none, arguing for a processive nature of the DNAmethyltrans-
ferase. In the second test, bisulfite treatment of a Lib-U of2384 Cell Reports 19, 2383–2395, June 13, 2017random 16-mers showed depletion of all CpN dinucleotides, as
expected (Figure 1C). In contrast, under optimal methylation
conditions, bisulfite treatment of a Lib-M showed depletion of
all CpN dinucleotides except CpG, which was recovered at
levels identical to those observed in non-bisulfite-treated, meth-
ylated libraries (Figure 1D).
EpiSELEX-Seq Identifies Differences in Methylation
Sensitivity within the bZIP Family
To benchmark our method, we considered the bZIP tran-
scription factors ATF4 and C/EBPb, previously reported to be
sensitive to DNA methylation (Mann et al., 2013). Many bZIP
homo- or heterodimers preferentially bind to the cyclic
AMP (cAMP) response element (CRE) TGACGTCA and/or the
C/EBP consensus TTGCGCAA (Figures 2A and 2B). These
palindromic sequences both contain a central CpG dinucleo-
tide, creating the potential for methylation-sensitive DNA bind-
ing. For ATF4 homodimers, as expected, the relative enrichment
of 10-bp sequences (encompassing the suspected TF footprint)
that do not contain any CpG dinucleotides is similar between
Lib-U and Lib-M (Figure 2C). However, sequences that contain
at least one CpG fall into distinct groups, each with a different
ratio between Lib-M and Lib-U, indicative of a sensitivity to
cytosine methylation that depends on the position of the CpG
dinucleotide within the binding site (Figure 2C; Figure S2A).
When a CpG base pair step is present at the center of the
ATF4 binding site, methylation of both cytosines leads to a
decrease in affinity. By contrast, sequences that contain a
CpG in the flank of the motif (at positions –3/–4 or +3/+4) are
bound much more strongly when methylated, leading to an
alternative optimal left half-site, (5mC)GAT. Interestingly, these
methylation sensitivities are not observed for C/EBPb (Fig-
ure 2D), consistent with a previous observation that in vivo bind-
ing by this factor tolerates CpG methylation (Zhu et al., 2016).
The methylation sensitivity for ATF4 is also reflected in the
energy logos (Foat et al., 2006) that can be derived from the
oligomer enrichment tables by considering all possible point
mutations away from the optimal sequence (Experimental
Procedures). The logo derived from Lib-M, compared with its
equivalent for Lib-U, no longer has a central CpG as the most
preferred sequence and shows an increased preference for a
CpG at position –4/–3 (Figures 2E and 2F). Together, these find-
ings demonstrate that sensitivity to DNA methylation can differ
between paralogs from the same structural family.
Feature-Based Modeling Quantifies Position-Specific
Methylation Effects
To systematically analyze the quantitative effect of cytosine
methylation on binding affinity, we developed a feature-based
generalized linear model to estimate the change in binding free
energy associated with cytosine modification at any particular
offset within the binding site. The frequency of DNA ligand S after
one round (R1) of affinity-based selection, F1, is proportional to
the frequency of the same probe in the initial (R0) pool, F0, as
well as to the relative affinity of the interaction:








Figure 1. Overview and Validation of the EpiSELEX-Seq Design
(A) Library design. 4-bp bar codes distinguish unmodified (Lib-U) and modified (Lib-M) DNA ligands. All libraries share a random region, reverse complement
symmetric flanks, and a pair of 50 and 30 primer sites.
(B) EpiSELEX-seq workflow. Lib-M is methylated and mixed with Lib-U. The mixed pool is incubated with a TF of interest, and the bound fraction is separated by
an EMSA, purified, split, and amplified using two sets of primers. Unique Illumina bar codes are added for multiplexing.
(C) Validation of the methylation protocol. Shown are dinucleotide frequencies in Lib-M after various combinations of optional methylation (M+/M–) and bisulfite
treatment (BsT+/BsT–), determined by Illumina sequencing. The four CpN dinucleotides for which the methylation status of the cytosine is unambiguous are
highlighted, as is TpG, which serves as a reference for CpN dinucleotides.
(D) TpG-normalized recovery of the four CpN dinucleotides. Only the CpGs protected by methylation are retained after bisulfite conversion. Error bars are based
on counting statistics and error propagation.We model DDGðSÞ, the difference in binding free energy
between ligand S, and the optimal ligand Sopt as a sum of contri-











Some features indicate the presence (X = 1) or absence (X = 0)
of a specific base at a given position within the binding site,
whereas others indicate the methylation status of a particular
CpG dinucleotide. We estimate the corresponding coefficients
bf from the data by fitting a generalized linear model based oncounting statistics to the read counts in R1 while accounting
for biases in R0 (see Experimental Procedures for details). To
validate this modeling approach, we first inferred free energy ef-
fects for the three possible substitutions of the optimal base A–5
using the ATF4 homodimer data. Good agreement is observed
with the results obtained using oligomer enrichment (Figure 2G).
Next we used an extended model that included features indi-
cating methylation status. The coefficients from this fit indicate
that methylation of C–1G+1 represses binding (DDG/RT = 1.5,
corresponding to 0.9 kcal/mol or equivalently, a 4.5-fold reduc-
tion in affinity), consistent with the changes in oligomer enrich-
ment between Lib-U and Lib-M (Figure 2H). The coefficients
for the equivalent flanking positions C–4G–3 and C+3G+4 areCell Reports 19, 2383–2395, June 13, 2017 2385
Figure 2. Probing Methylation Sensitivity for ATF4 and C/EBPb
(A and B) Crystal structure (PDB: 1GTW) for the human bZIP homodimer C/EBPb along with the symmetric consensus motifs for ATF4 (A) or C/EBPb (B) and the
definition of ‘‘flank’’ (green) and ‘‘center’’ (pink) positions in the binding sites.
(C) Enlargement of low-affinity range comparing the relative enrichment of 10-bp oligonucleotides between Lib-M versus Lib-U for ATF4. Non-CpG sequences
(blue) show similar enrichment in both libraries, whereas distinct subsets of the CpG-containing sequences (red) are either preferred in Lib-U (center) or in Lib-M
(flank).
(D) As in (C), but for C/EBPb homodimers. Non-CpG- andCpG-containing sequences show similar enrichments in both libraries across the entire sequence range.
The insets in (C) and (D) show the marginal distributions and the distribution of methylated/unmethylated ratio for all oligomers with a relative enrichment
above 103.
(E and F) Energy logo for ATF4 derived from Lib-U (E) and Lib-M (F). The central CpG is no longer the top choice in themethylated library. 5mCpGs at the equivalent
positions –4/–3 and +3/+4 appear as a new sequence feature in Lib-M.
(G) Relative affinities for ATF4 in Lib-U. Each point represents a 10-bp oligomer containing either an A (reference base) or a point mutation (C, T, or G) at position
–5. The slope of the lines represents the exponentiated value of -DDG/RT associated with each point mutation, as estimated from the Lib-U read counts using a
feature-based model.
(H) Comparison of binding free energies between Lib-M and Lib-U. Each point denotes a unique 10-mer. Vertical line offsets correspond to the position-
dependent methylation effects (DDG/RT) estimated using a feature-based (FB) model.almost identical, as expected based on symmetry, and indicate a
strong increase in binding because of methylation (DDG/RT =
–2.6). Our model also predicts the combined effect of methyl-
ating both C–1G+1 and C+3G+4 (or C–3G–4) by simply adding up
the respective free energy coefficients (Figure 2H).
Explaining the Effect of Cytosine Methylation by
‘‘Thymine Mimicry’’
Although it has distinct base-pairing preferences, 5mC is chem-
ically similar to thymine in that both have a methyl group at the
carbon 5 position of the pyrimidine ring (Figure 3A). Therefore,
the total effect of a C-to-T transition on protein-DNA binding
free energy, DDG½C/T, can be separated into the effect of
the methyl group alone, DDG½C/5mC; and changes in charge
and base pair interactions, DDG½5mC/T (Figure 3A). Following
this logic, the value of DDG½C/T and DDG½5mC/T, as esti-
mated using Lib-U and Lib-M, respectively, can be subtracted
from each other to obtain an estimate of the effect because of
methylation DDG½C/5mC. This approach was successful
when applied to ATF4 to predict the effect of methylating the
CpG dinucleotide, both at the central (–1/+1) and the flanking
(–4/–3) positions (Figures 3B–3D). In agreement with these ob-2386 Cell Reports 19, 2383–2395, June 13, 2017servations, many bZIP proteins contain two conserved hydro-
phobic amino acids that, in crystal structures, make van der
Waals (VdW) contacts with the carbon 5 methyl group of thymi-
dine at position –4 in the binding site (Figure S2B). C/EBPb, but
not ATF4, has a valine instead of an alanine at one of these
positions, providing a possible mechanistic explanation for the
increased preference of ATF4 for 5mC over C, where the gain
of a methyl group on the base may compensate for the loss of
a methyl group in alanine compared with valine.
Deciphering the DNA Binding Specificity of Human Pbx-
Hox Complexes
An important aspect of gene regulation is the capacity of TFs to
form complexes with cofactors. A prominent example of such
cooperative binding is that of Hox proteins and their three amino
acid loop extension (TALE) cofactors, which play a crucial role in
animal development (Merabet and Mann, 2016). As monomers,
Hox family members bind to similar DNA sequences in vitro
but have distinct functions in vivo. Previously, we used SELEX-
seq to capture the latent binding specificity of all eightDrosophila
Hox proteins with their TALE cofactors Extradenticle (Exd) and
the HM isoform (HM) of Homothorax (Hth), which is required
AB C D
Figure 3. Deconvolving the Methylation Sensitivity for ATF4
(A) Decomposition of the position-specific DNA-protein binding free energy change associated with a C/T transition. The C/T change is the sum of C/5mC
and 5mC/T, allowing an interpretation of methylation sensitivity in terms of thymine mimicry.
(B) Change in binding free energy associated with C/T transition in each library as derived from an oligomer-based PSAM.
(C) Position-specific methylation effect on binding free energy as estimated based on either the oligomer-enrichment-based approach (as in B, gray) or the
feature-based-modeling approach (red).
(D) The methylation effect, as estimated using the feature-based model (red arrows), explains the differences in the C/T transition effect observed for Lib-U and
Lib-M.for optimal Exd-Hox interaction (Slattery et al., 2011). In mam-
mals, where the Hox cluster has been duplicated several times
in the genome, multiple cofactors from the PBC and MEIS class
of TALE factors as well as epigenetic DNA modifications all have
the potential to modulate DNA binding.
Here we used EpiSELEX-seq to characterize the binding of
human heterodimeric Pbx-Hox complexes to DNA (Figure 4A).
To cover the three Hox subclasses defined in Slattery et al.
(2011), we performed these experiments using HoxA1, HoxA5,
and HoxA9, each in complex with the cofactor PBX1, which was
purified together with the HM domain of MEIS1. Comparing the
pattern of 12-bpoligomer enrichment fromR0 toR1 for eachcom-
plex, we found similar cofactor-dependent differences in binding
specificity between these Hox proteins, as previously observed
for theirD.melanogasterorthologs (Slatteryet al., 2011; Figure 4B;
FigureS4A): thepreferredcentral dinucleotidespacer (underlined)
in thebindingsiteconsensusNTGAYNNAYNNN(whereYdenotes
C or T) is TG for the anterior (class I) factor HoxA1, TA for the cen-
tral (class II) factor HoxA5, and TT for the posterior (class III) factor
HoxA9 (Figure 4D).
Human Pbx-Hox Dimers Show Position-Specific
Methylation Sensitivity
The EpiSELEX-seq protocol allows us to assess the three hu-
man Pbx-Hox complexes for sensitivity to cytosine methylation.
We first constructed separate energy logos for Lib-U and Lib-M
by considering all possible point mutations from the most en-riched 12-bp sequence (Figure 4D). Although paralog-depen-
dent differences in the central spacer (shaded area) are readily
apparent, the logos for the Lib-U and Lib-M human libraries
are otherwise highly similar to each other and to those of
their fly orthologs. However, this oligomer enrichment-based
approach is unable to detect methylation sensitivity for any cyto-
sine that does not occur in a CpG context in the optimal
sequence (Figure S3). For ATF4, both cytosine positions at
which methylation sensitivity was observed (–4 and –1) were
fortuitously followed by a guanine (cf. Figure 2A), but this is
not the case for Pbx-Hox. Indeed, when we used our feature-
based Poisson regression model to jointly analyze Lib-U and
Lib-M to quantify the effect of 5mCpG on binding, all three
Hox proteins and Pbx showed significant methylation sensitivity
at various positions throughout the binding interface (Figures 4C
and 4E; Figure S4B). The direction and amplitude of the methyl-
ation effect are highly position-dependent: methylation of CpG
dinucleotides that start at positions 5 or 9 (underlined in the
consensus sequence NTGAYNNAYNNN) enhance binding by
severalfold. In contrast, methylation of CpGs shifted by one
position (positions 6 or 10, underlined in NTGAYNNAYNNN) de-
creases binding by up to 7-fold (Figure 4E). This is reflected in
both the energy coefficients (lines in Figure 4E) and in the relative
enrichment of 12-mers (points in Figure 4E and Figure S4C). We
tested these predictions using competition DNA binding exper-
iments. Consistent with our EpiSELEX-seq analysis, using bind-
ing sites that contain a CpG at position 9/10 revealed that aCell Reports 19, 2383–2395, June 13, 2017 2387
Figure 4. Methylation Sensitivity of Human Pbx-Hox Complexes
(A) Crystal structure (PDB: 1PUF) of human Pbx-HoxA9, with Hox shown in blue and Pbx in green. The consensus sequence with position labels is shown as a
reference.
(B) Relative affinity comparison of Pbx1 plus HoxA1, HoxA5, or HoxA9 (green, orange, and red, respectively). Each Hox prefers distinct sets of 12-mers. Preferred
central spacers (positions 6 and 7) are TG, TA, and TT for HoxA1, HoxA5, and HoxA9, respectively.
(C) Replicate agreement for EpiSELEX-seq of Pbx1-HoxA9. Methylated/unmethylated (M/U) ratios for 12-mers are shown for one replicate versus the other.
Sequences with or without CpGs are shown in red or dark blue, respectively (Pearson correlation of 0.92). Staggered density plots show a narrow distribution of
non-CpG 12-mers around 1 but a much broader and bimodal distribution for CpG 12-mers.
(D) Oligomer-based energy logos for all three Pbx-Hox complexes for Lib-U and Lib-M. No obvious differences between the methylated and unmethylated
libraries are observed. The central spacer is shaded in gray.
(E) Lib-M versus Lib-U relative affinity plots for all three complexes. Points are colored based on the position of the CpG dinucleotide (dark blue for non-CpG
sequences). The slopes of the lines represent the exponentiated free energy coefficient for the methylation effect in the feature-based (FB) model.higher concentration was required for unmethylated (inhibitor
concentration at which the response is reduced by half [IC50] =
45.5 ± 14.7) than for methylated (IC50 = 20.3 ± 2.6) binding sites
to compete with a radioactively labeled consensus probe for
Pbx-HoxA1 binding (Figure S5).2388 Cell Reports 19, 2383–2395, June 13, 2017Thymine Mimicry Explains Variation in Methylation
Sensitivity among Hox Paralogs
The effect of methylation on binding not only depends on
the position of the CpG dinucleotide within the protein-DNA
interface but also differs between Hox paralogs (Figure 5A). At
AB
Figure 5. Collinearity of Methylation Sensitivity Explained by Struc-
tural Differences
(A) Comparison of the methylation effect for all three Pbx-Hox complexes. The
two A9 replicates are shown in different shades of red and have good
agreement (blue asterisks indicate that coefficients were fit at sub-optimal
affinity thresholds because of low counts). Position 9/10 shows large paralog-
dependent differences, with HoxA1 having high, HoxA5 medium, and HoxA9
almost no methylation sensitivity; position 5/6 shows the opposite trend.
(B) Comparison of Hox-specific C or T readout for position 9. HoxA1 prefers a
T over a C, whereas HoxA9 has equal preference. The observed difference
in binding free energy associated with a C/T transition should equal the
methylation sensitivity difference between HoxA1 and HoxA9. Alignment of
helix3 of several Hox TFs (B1, A1, A5, A9) reveals conservation of Ile47 for the
Hox family but polymorphism at residue 43. Ile47 interacts with the pyrimidine
at position 9 in both the HoxB1 and the HoxA9 structures. The distance to the
aromatic carbon 5 is 5.4 A˚ for HoxB1 but only 3.9 A˚ for HoxA9. Addition of a
methyl group in HoxB1 reduces the distance to 4.0 A˚, allowing for the same
VdW interaction as seen in HoxA9. Arg43 (A9) aids in bringing Ile47 closer to
the DNA by interacting with the phosphate backbone at nucleotide C9,
whereas Thr43 (B1/A1) does not interact with the backbone but, rather, pullsdinucleotide positions 5/6 and 9/10, the strength of methyla-
tion sensitivity is collinear with the Hox expression domain
along the anterior-posterior axis (HoxA1-HoxA5-HoxA9), similar
to other aspects of Hox function (Slattery et al., 2011).
To gain more insight into the structural mechanisms under-
lying these differences in binding, we compared HoxA1
and HoxA9, which show distinct differences in methylation
preference at position 9: Pbx-HoxA1 strongly prefers T over C
(DDG½C/T=RTz 2:0), whereas Pbx-HoxA9 shows no such
preference (Figure 5B). Close examination of a Pbx-HoxB1
(a proxy for HoxA1) crystal structure reveals that isoleucine at
position 47 (Ile47) within the homeodomain has a VdW interac-
tion with the carbon 5 methyl group on base T9 of the forward
DNA strand (Figure 5B). In contrast, in a Pbx-HoxA9 crystal
structure, Ile47 is closer to and interacts with the C9 base
even without this methyl group. Accordingly, we would predict
that HoxB1/A1 should benefit from the methylation of a C9,
whereas HoxA9 should be indifferent to methylation. Indeed,
DDG½C9/T9=RT is similar to ðDDG½C9/5mC9=RTÞ for
HoxA1, whereas, for HoxA9, DDG½C9/5mC9=RT is close to
zero (Figure 5B). Because the crystal structures show no further
base-specific interactions at position 9, these differences can be
fully accounted for by the relative benefit of gaining a methyl
group for each paralog.
EpiSELEX-Seq Identifies Non-consensus p53 Binding
Sequences Whose Affinity Is Increased upon
Methylation
Because alteredmethylation patterns are observed inmany can-
cers, we tested whether binding by the human tumor suppressor
protein p53 might be methylation-sensitive. In vivo, p53 is
thought to bind as a tetramer to two dimer sites, RRRCWWGYYY
(which we will refer to as CWWG), separated by a spacer of
0–13 bp (el-Deiry et al., 1992; Funk et al., 1992; Figure 6A).
Consistently, the palindromic sequence GGACATGTCC site
independently emerged from our data as the most enriched
10-mer in both Lib-M and Lib-U (Figure S6A). Comparing
Lib-M and Lib-U directly reveals that there are three different
classes of CpG-containing sequences that show altered p53
binding upon methylation (Figure 6A). Methylation of a CpG
occurring at the 30 end of the half site (RRRCATGYCG, which
we will refer to as C+4G+5, relative to the motif center) decreases
binding by 20%, whereas methylation at a CpG shifted 1 bp to
the left (RRRCATGCGY or C+3G+4) increases binding by 50%.
The largest effect, an 250% increase in binding affinity, was
observed when the CpG was in the core of the binding site
(RRRCACGYYY or C+1G+2). Analysis of a p53 crystal structure
(3Q06; Petty et al., 2011) reveals that the methyl group at carbon
5 of the T+1 base pyrimidine ring in the CATG core is stacked
above the polar guanidinium plane of p53 amino acid R280.
The latter is crucial for p53 binding because it forms
hydrogen bonds with the G+2 base (Figure 6B). The thymineIle47 away from T9. The C/T energy difference between HoxA1 and HoxA9 is
most likely driven by the methyl readout. The table shows that the C/T free
energy difference is comparable with the difference in methylation sensitivity
(feature-based model) between the two paralogs.
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Figure 6. p53 Differentially Binds Methylated Motifs In Vivo in Distinct Chromatin Modification States
(A) EpiSELEX-seq 10-mer relative affinity plot showing the consensus motif (RRRCWWGYYY, blue) and three classes of CpG-containing motifs. CpG motifs are
differentially bound upon methylation, with methylation of C4+G5+ (green) half-sites reducing binding about 20%, whereas methylation of C3+G4+ (cyan) and
C1+G2+ (pink) sites increases binding 1.5-fold and 2- to 3-fold, respectively. Non-CpG consensus sites, as expected, show no difference between Lib-U and
Lib-M. The slope of the lines represents the value of DDG associated with methylation at each of the identified CpG positions using the feature-based model;
methylation effects related by reverse-complement symmetry, estimated independently, are shown as separate lines.
(B) p53 structure (PDB: 3Q06) showing the DNA interface of a p53 dimer with the RRRCAjTGYYY core (labeled ± relative to the motif center). The two arginines
(R280) form hydrogen bondswith the respective G+2 bases of each pentamer half-sites (2.5 and 3.0 A˚, red) guided by themethyl groups of the pyrimidine carbon 5
of the T+1 base, which stack on top of the polar guanidinium plane (3.9 and 4.0 A˚, green), thus constraining the possible orientations of the positive charge in favor
of forming hydrogen bonds with G+2. Methylation of a T+1/C+1 substitution would therefore result in stabilization because of regaining a methyl group at
position +1.
(C) Comparison of motif-centric analysis and MACS2 peak calling. Left: distribution of induction levels (defined as the logarithm of the ratio of drug-induced and
uninduced IP coverage) for all covered CATG or C1+G2+ sites (m= mean and s= SD). Right: fraction of decamer sites overlapping with MACS2 peak regions
split by their log-transformed induction. For all three drugs and both the consensus CATG and the C1+G2+ motifs, there is a highly significant trend between
motif-centric induction levels and MACS2 peak calling.
(legend continued on next page)
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methyl group might thus direct and constrain R280 toward G+2,
which has been proposed to serve as a methylation readout
mechanism of zinc-finger proteins (Liu et al., 2013). T+1/C+1
replacement would thus eliminate the guiding methyl group,
providing an explanation for the stabilizing effect of methylation
at position C+1.
Evidence for Enhanced p53 Binding to Methylated Sites
In Vivo
When unmethylated, sequences of type C+1G+2 are bound by
p53 at a relative affinity of <10%. However, our analysis shows
that binding to these sites is strongly enhanced by cytosine
methylation. To test whether this effect on in vitro binding is
also observable in vivo, we jointly analyzed whole-genome bisul-
fite sequencing (ENCODE Project Consortium, 2012) and p53
genomic occupancy data—generated by ChIP-seq both before
and after induction of p53—for the cell line MCF7 (Nikulenkov
et al., 2012). Using standard peak calling (Zhang et al., 2008)
at a false discovery rate of 5%, we detected 40 sites that were
both occupied by p53 and had an underlying DNA sequence
containing a match to RRRCACGYYY, a sample too small to
allow for statistical analysis of the effect of methylation status
(Figure S6B). Moreover, the negative effect of methylation on
chromatin accessibility in vivo may obscure the positive effect
on binding suggested by our SELEX analysis. To address this
issue, we developed amotif-centric analysis strategy that avoids
peak calling. We started by identifying all individual matches
to the most strongly bound RRRCATGYYY sites in the genome
and classifying each of these p53 half-sites in terms of the
change in the number of ChIPed DNA fragments covering it
before and after p53 induction. We observed a strong and statis-
tically significant trend between motif-centric fold induction and
the probability of falling within a peak region based on model-
based analysis of ChIP-seq (MACS2) (Figure 6C), indicating
that this approach captures the underlying p53 binding signa-
ture. In addition, this trendwas robust for three different inducers
of p53 activity and was also observed for the CpG-containing
C+1G+2 motif (Figure 6C).
Encouraged by this observation, we used a generalized linear
model that explains how the number of sequenced immunopre-
cipitation (IP) fragments covering an individual genomicmatch to
any of the four decamer half-site motif classes (CATG, C+1G+2,
C+3G+4, and C+4G+5) is distributed between the uninduced and
induced conditions. The CATG motif, which does not match
any CpG-containing decamers, serves to estimate the effect of(D) Feature model fits of drug-induced (5FU, Nutlin, and RITA) in vivo P53 ChIP-se
CpG density within a 500-bp region as context-dependent predictors and thre
sampled to 50 sites for each possible methylation-motif combination (see Experim
with red signifying positive and blue negative effects on binding. Z scores for C1
dependent, confounding model predictors (highly significant across all drugs).
(E)Methylation coefficients for the C1+G2+ sites were computed on the entire datas
uninduced and drug-induced p53 IP coverage. The pink area shows the expecte
(F) Overlap with peaks of histone modifications (<1 kb) for methylated and unmeth
methylation-matched random control sets (light shade) show the expected overlap
but not marks of active transcription, are significantly enriched in methylated C1
scription (H3K4me1, H3K4me3, and H3K27ac), perhaps reflecting increased acc
(G) Potential mechanism of how aberrant methylation patterns might contribute t
landscape and gene regulation.local chromatin context, which is represented by the average
methylation level and CpG content of the flanking regions as pre-
dictors in the model. To account for variation in binding affinity
unrelated to methylation, we also included as a covariate the
relative affinity of the 10-bp half-site as derived from the DNA
sequence using a scoring matrix derived from our Lib-U data
(see Experimental Procedures and Supplemental Experimental
Procedures for details). Finally, and most importantly, the coeffi-
cients associated with three binary indicators for the presence of
a methylated CpG dinucleotide at each offset quantify the effect
of cytosine methylation on the responsiveness of in vivo p53
binding.
When the model is fit to ChIP-seq data, the position-depen-
dent effects of cytosine methylation within the binding site iden-
tified by our EpiSELEX-seq assay are recapitulated in MCF7
cells, with methylation of C+1G+2 having a significant stabilizing
effect (Figure 6D). The coefficients for the confounding contribu-
tions in the model also behave as expected, with positive effects
for CpG density and sequence-derived p53 affinity and a nega-
tive effect for regional methylation (Figure 6D). Considering
that the in vivo methylation effects should more closely reflect
the in vitro effect at higher levels of ChIP enrichment, where
the local chromatin context is, presumably, more permissive,
we repeated our model fit using increasing cutoffs on the sum
of induced and uninduced read counts for all consensus
matches in the genome (Figure 6E). The coefficient for C+1G+2
behaves as expected and saturates at DD G/RT = +1.5, corre-
sponding to an 4.5-fold increase in binding affinity upon full
methylation of the CpG dinucleotide (Figure 6E). Thus, the in vivo
methylation effect appears to be even higher than in vitro, which
could reflect contributions from additional methylated CpG dinu-
cleotides within the full p53 tetramer binding site or cooperativity
with other factors. For the other two motif classes (C+3G+4 and
C+4G+5), the coverage by IP fragments is too sparse to allow
quantification, consistent with the weaker in vitro methylation
sensitivity observed for these CpG offsets with our EpiSELEX-
seq assay.
It has been suggested that p53 can bind to high-nucleosome-
occupancy regions and act as a pioneer factor to alter chromatin
accessibility (Laptenko et al., 2011; Sammons et al., 2015). We
therefore analyzed five histone modifications that, in combina-
tion, can be used to classify enhancers or promoters as active,
closed, or primed (Calo and Wysocka, 2013). Methylated
C+1G+2 sites are significantly enriched for H3K9me3 and
H3K4me1 but not H3K27ac (associated with active enhancers)q data for MCF7 using Lib-U relative affinities, average methylation levels, and
e position-specific binary methylation indicator features. Datasets were sub-
ental Procedures for details). Top: the significance of the methylation features,
+G2+ ranges from 3.0 (5Fu) to 6.3 (Nutlin). Bottom: the scores for the context-
et using the feature-basedmodel from (D), with increasing cutoffs on the sumof
d difference in binding free energy from EpiSELEX-seq results.
ylated C1+G2+ motifs (>2 SD above mean induction, dark shade). Equally sized,
. Primed enhancer (H3K4me1) and heterochromatin (H3K9me3) modifications,
+G2+ sites, whereas unmethylated C1+G2+ sites show patterns of active tran-
essibility at active promoters.
o altered p53 binding and, thus, potentially contribute to changes in chromatin
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or H3K4me3 (associated with active transcription) compared
with a matched control set (see Experimental Procedures for
details; Figure 6F). These histone modifications have been sug-
gested to mark either heterochromatin (H3K9me3) (Grewal and
Jia, 2007) or enhancers that are primed to become active
(H3K4me1) (Calo and Wysocka, 2013). We observed the same
pattern for CATG sites within methylated regions (Figure S6C).
By contrast, unmethylated C+1G+2 sites tend to have a strong
signature of H3K4me1 and H3K4me3 or H3K27ac (Figure 6F),
arguing that ChIP enrichment at those loci may be due to tran-
scriptional activity rather than specific p53 targeting. This again
underscores the need to account for confounding effects when
analyzing in vivo binding data.
Interestingly, 67 of 90 (74%, with 44% expected, p = 3 3
1010) of the methylated C+1G+2 sites occur within 3 kb of
a protein-coding gene (60 genes total) or long non-coding
RNAs (lncRNAs) (20 total) (Figure S6D) annotated in GENCODE
(Derrien et al., 2012). The enrichment for sites occurring near
lncRNAs (21 of 90 sites or 23%, with 8% expected, p = 5 3
107) (Figure S6D) is consistent with previous findings about
p53 regulation of lncRNA expression (Le´veille´ et al., 2015).
DISCUSSION
With EpiSELEX-seq, we have developed a method that can
accurately quantify the change in binding free energy associated
with the presence of a methylated cytosine at any position within
the protein DNA interface. A key aspect of our approach, which
allows us to robustly identify methylation sensitivity, is that modi-
fied and unmodified DNA ligands are probed simultaneously in a
single reaction, ensuring a direct comparison of TF occupancy.
One round of selection is sufficient to accurately capture methyl-
ation effects, even for lower-affinity sites that deviate from the
consensus and, thus, readily escape detection when binding to
methylated and unmethylated ligands is assayed separately or
over multiple rounds of selection. The context-sensitive nature
of our analysis is essential because opposingmethylation effects
can occur within a single binding site, making it difficult or impos-
sible to detect the effect of methylation using less precise ap-
proaches, such as oligomer enrichment only. This point is illus-
trated by our analysis of human Pbx-Hox heterodimers, whose
DNA binding specificity we studied here for the first time at
high resolution. The net effect of methylation on binding is close
to neutral, but methylation of different CpGs in the binding site
can modulate the binding affinity by up to 7-fold in either direc-
tion. This also illustrates why it may be difficult to detect methyl-
ation sensitivity by looking at motif enrichment in differentially
methylated regions (DMRs). Pbx-Hox sequence logos con-
structed separately for the unmethylated and methylated li-
braries were nearly indistinguishable and did not reveal signifi-
cant methylation sensitivity of Pbx-Hox complexes (Figure 4D).
Only when we examined the consequences of methylation at
specific positions were we able to identify clear effects.
Despite an ongoing debate concerning to what extent CpG
methylation is a driver of gene silencing or the consequence
thereof (Ambrosi et al., 2017), the general view is thatmethylation
has a repressive effect on TF binding. For example, in a study
that compared binding of TFs between wild-type and Dnmt12392 Cell Reports 19, 2383–2395, June 13, 2017knockout embryonic stem cells (ESCs) (Domcke et al., 2015),
the authors showed that removal ofmethylationmarks at specific
nuclear respiratory factor 1 (NRF1) binding sites led to increased
binding and expression of nearby genes. In addition, experimen-
tally induced methylation reduced NRF1 binding to those sites.
Here, and in agreement with recently published data (Yin et al.,
2017), we demonstrate that endogenous methylated motifs con-
taining a CpG at specific sites within the protein-DNA interface
can also increase binding and that the mechanisms underlying
the epigenetic control of TF binding and, thus, gene expression
are more nuanced than previously thought.
For p53, despite a general negative effect of regional methyl-
ation on genomic occupancy, the increased binding to methyl-
ated RRRCACGYYY sites our analysis revealed implies that
methylated binding sites are functional and might direct p53 to
alter previously inaccessible loci in the genome. This conclusion
is supported by our finding that these occupied and methylated
binding sites are associated with a histone modification pattern
that indicates either compacted chromatin (Grewal and Jia,
2007) or transcriptionally poised enhancers. Additional evidence
that p53 can access nucleosomal DNA in vitro and in vivo and,
thus, might be a pioneer factor also supports this notion (Lap-
tenko et al., 2011; Sammons et al., 2015). Many diseases, in
particular many forms of cancer, are accompanied by aberrant
methylation patterns (Kulis and Esteller, 2010), raising the ques-
tion whether even subtle changes in the methylome could trigger
differential TF binding and, thus, contribute to the onset of dis-
ease. Interestingly, H3K4me1 has also been shown to be signifi-
cantly associatedwith loss ofmethylation during aging inmultiple
humancell types (Ferna´ndez et al., 2015), providing yet additional
support for the functionality and importance of such sites.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification
Human proteins, either full-length or nearly full-length, were affinity-purified
using a polyhistidine tag (HIS). p53 protein was purified as described in Lap-
tenko et al. (2015), containing a deletion in the C-terminal basic region to pre-
vent non-specific DNA binding contributions outside of the core DNA-binding
domain.
Library Design and Methylation
Full library sequences were as follows: 50-GGTAGTGGAGG-TGGG-CCTGG-
16(26)xN-CCAGG-GAGGTGGAGTAGG-30 for Lib-U and 50-GGTAGTG-
GAGG-GCAC-CCTGG-16(26)xN-CCAGG-GAGGTGGAGTAGG-30 for Lib-M.
Libraries were double-stranded by annealing and extension using Klenow po-
lymerase (New England Biolabs). Lib-M was methylated with M.SssI (NEB) us-
ing only250 ng/13 reaction and two subsequent incubation cycles of 2 hr at
37C each. Up to 400 ng of 13 methylated DNA can be combined in the sec-
ond step using Oligo-Clean-up columns (ZymoGenetics) for purification.
EpiSELEX-Seq Protocol
EMSAs and extraction of bound DNA were performed as described previously
(Slattery et al., 2011) with an equal mix of Lib-U and Lib-M. Purified, bound
DNA was split in two and amplified using a 15-cycle PCR protocol with high-
fidelity enzymes (Phusion or Q5, NEB), with overhang primers adding TruSeq
Illumina adaptor sites in two orientations, respectively, to allow sequencing
from both 50 and 30 ends. Efficient splitting was analyzed by comparing the
number of reads resulting from each set of primers (Figure S1). Specific Illu-
mina bar codes were added by a five-cycle PCR using NEBNext Multiplex Oli-
gos for Illumina sequencing and Phusion/Q5 polymerase. Indexed libraries
were gel-purified as described previously (Slattery et al., 2011), pooled, and
sequenced using a v2 75-cycle high-output kit on an Illumina NEXTSeq series
desktop sequencer. For initial (R0) and enriched (R1) libraries, 5–35 million
single-end reads were obtained.
Testing for Methylation Efficiency
A DNA probe containing four CpG sites was methylated, bisulfite-treated, and
cloned into the pBlueScript vector; four to eight colonies were picked for
sequencing. We assessedmethylation efficiency by counting retained CpG di-
nucleotides. Alternatively, Lib-M was split into three parts (methylated and not
treated, methylated and treated, unmethylated and treated with bisulfite) and
prepared for sequencing as described above. Dinucleotide frequencies were
computed, and CpN ratios were compared across all treatments to assess
methylation efficiency using ‘‘TpG’’ as a reference.
EpiSELEX-Seq Data Processing
FASTQ files were pre-processed using the FASTX toolkit (Hannon lab). Files
were reverse-complemented, merged, and trimmed to have unidirectional
reads starting from the 4-bp bar code site. Each dataset was assigned to either
Lib-U or Lib-M. A fifth-orderMarkovmodel was generated from the R0 libraries
for Lib-U and Lib-M, respectively, using the R package bioconductor.org/
packages/SELEX (Riley et al., 2014).
Oligomer Enrichment Analysis
Relative affinities for oligomers of length k were estimated as described previ-
ously (Slattery et al., 2011). Fold enrichments were normalized based on the
most enriched oligomer for each library. Position-specific affinity matrices
(PSAMs) (Foat et al., 2006)were generatedby considering all 3kpointmutations
away from the most enriched oligomer. Binding free energy differences
DDG=RT between the mutated and optimal sequence were computed as the
negative logarithm of the relative fold enrichment. The binding free energy
change DDG=RT for a C/T transition was calculated separately for Lib-U
and Lib-M and used to estimate the effect of methylation on binding as follows:
DDG½C/5mCzDDG½C/TLibU--DDG½C/TLibM:
Feature-Based Modeling
A feature-based Poisson regression model was fit to the R1 read counts. First,
PSAMs were constructed from oligomer enrichment tables for each sample
and used to estimate relative binding affinity in either orientation and at each
offset relative to the random region, allowing for up to 2-bp overlap with the
constant flanks. Only probes for which a single offset/orientation contributing
at least 95% of the total were kept. To avoid bias, R1 reads were randomly
split; one half was used to define the set of oligomers that correspond to the
rows in the design matrix and the other to obtain R1 counts. Regression
models were fit in two ways: (1) using the Lib-U R1 count for a particular motif
of length k, the Markov model prediction from the corresponding R0 as an
offset, and 4k base indicator features at each position in the motif as indepen-
dent variables; (2) the same as before but including Lib-M and using both base
and 5mCpG features. As expected, adding 5 mCpG features and jointly fitting to
Lib-U and Lib-M did not affect the base feature estimates (Figure S1C). For
p53, a separate intercept was fit for each library.
Competition Assay for Pbx-HoxA1
Two 12-mer competitor probes with identical sequence—ATGATTGACGAC—
but different methylation statuses at position 9 were tested for their capacity to
compete with a labeled probe for Pbx-HoxA1 binding in an EMSA. Pbx-HoxA1
and labeled probe concentrations were held constant while increasing the
concentrations of the unlabeled competitor DNA over a 1,000-fold range.
Experiments were performed in duplicate. IC50 values were calculated using
ImageJ for quantification and R-package drc to fit a dose-response curve.
Data Processing for In Vivo p53 Binding
We downloaded ChIP-seq data (FASTQ files, Sequence Read Archive
accession number: SRP007261) for p53 in MCF7 cells (no-drug control and
drugs Nutlin, reactivation of p53 and induction of tumor cell apoptosis
[RITA], and fluorouracil [5FU]), and MCF7 whole-genome bisulfite sequencingdata (browser extensible data [BED] file, GSM1328112). FASTQ files
were aligned to hg19 (Bowtie2) and converted to coverage tracks (deep-
tools/bamCoverage) after extending reads by 200 nt. MACS2was run with op-
tions –g hs and –q 0.05 using the uninduced p53 IP as a control. BED peak files
(hg19) for five histone modifications in MCF7 were downloaded (ENCODE:
ENCSR000EWP, ENCSR000EWQ, ENCSR000EWR, ENCSR493NBY, and
ENCSR985MIB). General transfer format (GTF) files for the current releases
(v25) of human whole-genome annotation and lncRNA-specific annotation
data were downloaded from GENCODE (mapped to GRCh37/hg19).
In Vivo Motif-Centric p53 Binding Analysis
Analysis was done in R. The hg19 genome was scanned for sites mapping
to the consensus RRRCATGYYY or the three CpG-containing motif classes
(RRRCATGYCG, RRRCATGCGY, and RRRCACGYYY). CpG sites were
intersected with whole genome bisulfite sequencing (WGBS) BED files, and
methylation status was assigned based on the percentage methylated
(‘‘1’’ for > 80% and ‘‘0’’ for < 10% methylated), keeping only sites withR 103
coverage. Average methylation levels and CpG density of the 500 bp
centered around the motif were computed, and the per-motif p53 coverage
for uninduced (control) and drug-induced (IP) were obtained, keeping only
motifs with R 13 coverage in both control and IP. Individual genomic motif
occurrences correspond to the rows of the design matrix (X); columns are
the in vitro 10-mer affinities (unmethylated EpiSELEX-seq), the three position-
specific binary 5mCpG indicators, average methylation level, and CpG density.
Theglm functionwith family = ‘‘binomial’’ wasused inR to fit the followingmodel
















Regression coefficients and Z scores quantifying their statistical significance
were obtained for each model fit. To avoid bias in the size of motif classes in
the training data, sub-sampling (200 times) was applied in a way that guaran-
tees an equal number of occurrences of methylation status and motif class (for
the CATG motif, a 50% regional methylation level was used as a threshold).
Models for enriched p53 occupancy were fit by sequentially removing rows
for which the sum of drug-induced and uninduced IP fragment counts fell
below a certain threshold. Fisher’s exact test was used to compute statistical
associations between MACS2 peaks (1 kb around the peak summit) and
grouped motif-centered log-transformed enrichment values.
Overlap with GENCODE Annotation and Histone Marks
Enrichment for either GENCODE annotations or histone marks was scored by
computing the overlap between the motif sets (log induction > 2 SD above the
mean) and either the gene annotations (within 3 kb) or the histone peaks (within
1 kb). p Values were computed by generating >100 random methylation-
matched sets from theWGBS data and calculating the probability of observing
the actual overlap based on the sampling of random overlaps.
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